We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

300339:SZSEJiangsu Hoperun Software Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥44.63

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Jiangsu Hoperun Software is trading at CNY 44.63, well below its 20‑day (≈47.7), 50‑day (≈50.5) and 200‑day (≈54.0) simple moving averages, indicating a sustained bearish price trend. The MACD is in a bearish configuration and the RSI sits near 36, suggesting limited upside momentum but also that the stock is not yet deeply oversold. Volatility is high at roughly 39% over the past 30 days, while the beta of 0.04 points to minimal correlation with the broader market, implying that idiosyncratic risks dominate. Fundamentals are strained: a trailing PE of ~279 versus an industry average of ~34, a price‑to‑book of >10, a meager profit margin of 3.5%, negative free cash flow and a debt‑to‑equity ratio near 34% raise concerns about valuation and financial health. Revenue is growing at a solid 17% year‑over‑year, yet the low dividend yield (0.15%) and zero payout ratio signal that cash generation is insufficient to support shareholder returns. The market sentiment index shows “Extreme Greed,” but the technical picture, elevated valuation multiples, and weak cash fundamentals suggest that optimism may be overstated.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below all major moving averages
  • bearish MACD and modest RSI
  • high valuation multiples relative to peers

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • steady revenue growth but weak profitability
  • negative free cash flow and elevated debt
  • persistent market volatility

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside if cash flow turns positive
  • exposure to fast‑growing fintech and IoT segments
  • risk of regulatory tightening in Chinese tech

Key Metrics & Analysis

Financial Health

Revenue Growth17.30%
Profit Margin3.48%
P/E Ratio278.9
ROE3.66%
ROA1.81%
Debt/Equity33.86
P/B Ratio10.7
Op. Cash FlowCN¥19.7M
Free Cash FlowCN¥-326376864
Industry P/E34.5

Technical Analysis

TrendBearish
RSI36.1
SupportCN¥44.20
ResistanceCN¥52.68
MA 20CN¥47.70
MA 50CN¥50.50
MA 200CN¥53.97
MACDBearish
VolumeStable
Fear & Greed Index81.95

Valuation

Target PriceCN¥76.80
Upside/Downside72.08%
GradeOvervalued
TypeBlend
Dividend Yield0.15%

Risk Assessment

Beta0.04
Volatility39.24%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.